Getting your doctor(s) to talk to you about “the bad news”

There is an interesting article in the August 1 issue of the Journal of Clinical Oncology on why physicians and other health-care professionals don’t like to talk to their patients about “the bad news” when it comes to prognosis. … READ MORE …

Survival after a diagnosis of AJCC Stage IV prostate cancer

For many men, a diagnosis of prostate cancer of any stage or grade — even of the lowest level of risk — is hard to deal with. If they have progressive disease after first-line therapy, it may appear to be an overwhelming issue. … READ MORE …

Atul Gawande’s “Letting Go”

Atul Gawande is a general surgeon who practices in New York. He also writes regularly on issues related to the relationship between medicine and society. … READ MORE …

Leonard Salz, MD, on hope and hype

Some regular readers of the cancer literature may want to see an article just published in the Journal of Clinical Oncology by Leonard Salz, MD (a world-famous colorectal cancer specialist) on the way in which language affects perceptions in the world of cancer communication.

The article basically says we all need to be more specific about how we explain things like the difference between “significant” and “statistically significant” or what we mean by “toxicity was tolerable” in a clinical trial. And Dr. Salz makes many good points that The “New” Prostate Cancer InfoLink will do its best to take to heart!